Luke Jones
Postdoctoral Researcher
Postdoctoral researcher working on understanding the cellular and molecular basis of hepatitis D virus driven liver disease. My background is in virology more broadly, and in the past I've worked on a variety of projects, ranging from studying antivirals and nanobodies as therapeutics, coronavirus neurovirulence, and the link between viral infection and neurodegenerative disease.
Recent publications
Nanobodies against the S2 region of the spike protein potently neutralize SARS-CoV-2 viruses and show resistance to virus escape
Preprint
Clarke J. et al, (2026)
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Journal article
Chan XHS. et al, (2025), The Lancet Microbe, 6, 101002 - 101002
Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2
Journal article
Cornish K. et al, (2024), Open Biology, 14
Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials
Preprint
Chan XHS. et al, (2024)
Antiviral mechanism change of poly(styrene sulfonate) through gold nanoparticle coating
Journal article
Bhebhe LM. et al, (2024), Polymer Chemistry, 15, 945 - 951
